---
title: 'Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled
  stage 2b trial'
date: '2024-02-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38420108/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240229170544&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Open partial pancreatoduodenectomy (OPD) represents the
  current gold standard of surgical treatment of a wide range of diseases of the pancreatic
  head but is associated with morbidity in around 40% of cases. Robotic partial pancreatoduodenectomy
  (RPD) is being used increasingly, yet, no randomised controlled trials (RCTs) of
  RPD versus OPD have been published, leaving a low level of evidence to support this
  ...'
disable_comments: true
---
BACKGROUND: Open partial pancreatoduodenectomy (OPD) represents the current gold standard of surgical treatment of a wide range of diseases of the pancreatic head but is associated with morbidity in around 40% of cases. Robotic partial pancreatoduodenectomy (RPD) is being used increasingly, yet, no randomised controlled trials (RCTs) of RPD versus OPD have been published, leaving a low level of evidence to support this ...